See more : Elanco Animal Health Inc (ELAT) Income Statement Analysis – Financial Results
Complete financial analysis of ProSomnus, Inc. (OSA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ProSomnus, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Hyundai Motor Company (005387.KS) Income Statement Analysis – Financial Results
- SUNNEXTA GROUP Inc. (8945.T) Income Statement Analysis – Financial Results
- Fulcrum Metals plc (FMET.L) Income Statement Analysis – Financial Results
- Shinhan Financial Group Co., Ltd. (055550.KS) Income Statement Analysis – Financial Results
- Koshidaka Holdings Co., Ltd. (2157.T) Income Statement Analysis – Financial Results
ProSomnus, Inc. (OSA)
About ProSomnus, Inc.
ProSomnus, Inc. manufactures precision oral appliance therapy devices for the treatment of obstructive sleep apnea (OSA). The company was founded in 2016 and is based in Pleasanton, California.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 27.65M | 19.39M | 14.07M | 8.29M |
| Cost of Revenue | 13.64M | 9.13M | 6.76M | 4.17M |
| Gross Profit | 14.01M | 10.27M | 7.31M | 4.12M |
| Gross Profit Ratio | 50.67% | 52.94% | 51.94% | 49.73% |
| Research & Development | 4.80M | 2.98M | 1.89M | 1.47M |
| General & Administrative | 15.23M | 9.89M | 4.46M | 3.29M |
| Selling & Marketing | 13.09M | 8.87M | 5.78M | 3.52M |
| SG&A | 28.32M | 18.76M | 10.24M | 6.81M |
| Other Expenses | -770.00K | 553.24K | 0.00 | 10.00K |
| Operating Expenses | 33.12M | 21.74M | 12.13M | 8.28M |
| Cost & Expenses | 46.76M | 30.87M | 18.89M | 12.44M |
| Interest Income | 0.00 | 6.12M | 3.25M | 2.01M |
| Interest Expense | 5.38M | 6.12M | 3.25M | 2.01M |
| Depreciation & Amortization | 2.22M | -10.45M | 827.57K | 573.27K |
| EBITDA | -17.74M | -11.48M | -3.99M | -3.57M |
| EBITDA Ratio | -61.06% | -59.17% | -28.33% | -43.14% |
| Operating Income | -19.11M | -1.03M | -4.81M | -4.15M |
| Operating Income Ratio | -69.09% | -5.29% | -34.21% | -50.06% |
| Total Other Income/Expenses | -4.99M | 4.33M | -1.15M | -2.01M |
| Income Before Tax | -24.10M | -7.15M | -5.97M | -6.16M |
| Income Before Tax Ratio | -87.14% | -36.84% | -42.41% | -74.29% |
| Income Tax Expense | 0.00 | -10.45M | 7.65K | 17.67K |
| Net Income | -24.10M | 3.30M | -5.98M | -6.17M |
| Net Income Ratio | -87.14% | 17.04% | -42.47% | -74.50% |
| EPS | -1.49 | 0.33 | -1.51 | -0.38 |
| EPS Diluted | -1.49 | 0.33 | -1.51 | -0.38 |
| Weighted Avg Shares Out | 16.18M | 10.02M | 3.96M | 16.05M |
| Weighted Avg Shares Out (Dil) | 16.18M | 10.02M | 3.96M | 16.05M |
ProSomnus Announces Third Quarter 2023 Investor Call and Business Update
PLEASANTON, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), will report its third quarter financial results after market close on Thursday, November 9, 2023. ProSomnus Chief Executive Officer, Len...
ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference
PLEASANTON, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announces management's participation in the 2023 Roth Capital Healthcare Opportunities Conference at the Yale Club...
ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations
Company will leverage new capital inflow to optimize core business operations, advance strategic growth initiatives, and achieve cash flow breakeven Company will leverage new capital inflow to optimize core business operations, advance strategic growth initiatives, and achieve cash flow breakeven
ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences
Scientific Abstracts and Presentations Feature New and Additional Data Demonstrating the Efficacy, Effectiveness, and Safety of ProSomnus Precision Devices for the Treatment of Obstructive Sleep Apnea Scientific Abstracts and Presentations Feature New and Additional Data Demonstrating the Efficacy, Effectiveness, and...
ICR Hosts ProSomnus CEO Len Liptak on the Welcome to the Arena Podcast
NEW YORK--(BUSINESS WIRE)---- $OSA #IR--ICR, a leading strategic communications and advisory firm, is pleased to announce that Len Liptak, Co-Founder and Chief Executive Officer of ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea,...
ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results
PLEASANTON, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company” or “ProSomnus”) (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), today announced financial results for the second quarter ended June 30, 2023.
Oklahoma Sheriffs’ Association suspends three officials after recordings
247 News Around The World 247 News Around The World Three law enforcement officials have been suspended from the Oklahoma Sheriffs’ Association (OSA),… The post Oklahoma Sheriffs’ Association suspends three officials after recordings appeared first on 247 News Around The...
ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
PLEASANTON, Calif., March 16, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), the pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its fourth quarter and full year 2022 financial results after market close...
ProSomnus to Present at Two Upcoming Investor Conferences in March 2023
SAN FRANCISCO, March 01, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announces that Company management will participate in two investor conferences in the month...
Source: https://incomestatements.info
Category: Stock Reports